ReviewFrontiers in pharmacology2016
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
Yvonne W S Jauw et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
104 papers cite itlatest 60 shown
this paperpooled ittrialcites it